We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more
For more information, go to

Launch of the Centre for Inflammation and Therapeutic Innovation

Published on 08 November 2017

Last week we attended the launch of the new Centre for Inflammation and Therapeutic Innovation (CiTI) at Queen Mary University of London (QMUL), which we're pleased to be supporting through an investment in three new strategic positions.

Since 1983, QMUL have hosted an Arthritis Research UK Chair in Rheumatology through an initial endowment made at the time. Following consultation with us and associated due diligence by the University, QMUL monetised the remaining balance of this endowment enabling the development of a new model of funding that would ensure a long-lasting commitment to musculoskeletal research, in part through the newly established CiTI. 

We're pleased to announce that this investment by QMUL has been used to support two new Arthritis Research UK Chairs, appointed as of 1st September 2017:

  • Arthritis Research UK Professor of Inflammation Sciences, held by Antal Rot
  • Arthritis Research UK Professor of Experimental Medicine and Rheumatology, held by Costantino Pitzalis.

Both chairs are recognised leaders in their disciplines of immunology and experimental medicine. Through this new development, QMUL have also committed forward financial support and expenses to maintain these posts in the long term, thus significantly augmenting their leading programme of rheumatology research.

Additionally, to underpin this University investment, we will also establish a five-year Arthritis Research UK clinical lecturer in experimental medicine and rheumatology, working under the direction of the two Arthritis Research UK professors at CiTI.

The three new strategic posts will form a central part of CiTI at QMUL, which was formally launched on 1st November 2017. The aim of this new multi-disciplinarary centre is to accelerate the advancement of research discoveries into improved patient care. CiTI has attracted an impressive portfolio of UK and international funding to support this aim, and will host leaders in discovery and translational research supported by organisations including Wellcome and MRC.

For more information, go to
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.